Literature DB >> 35026016

Proton vs photon radiation therapy for glioblastoma: Maximizing information from trial.

Ivan R Vogelius1,2, Søren M Bentzen3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35026016      PMCID： PMC9071317          DOI： 10.1093/neuonc/noab261

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   13.029


× No keyword cloud information.
  1 in total

1.  A prospective phase II randomized trial of proton radiotherapy vs intensity-modulated radiotherapy for patients with newly diagnosed glioblastoma.

Authors:  Paul D Brown; Caroline Chung; Diane D Liu; Sarah McAvoy; David Grosshans; Karine Al Feghali; Anita Mahajan; Jing Li; Susan L McGovern; Mary-Fran McAleer; Amol J Ghia; Erik P Sulman; Marta Penas-Prado; John F de Groot; Amy B Heimberger; Jihong Wang; Terri S Armstrong; Mark R Gilbert; Nandita Guha-Thakurta; Jeffrey S Wefel
Journal:  Neuro Oncol       Date:  2021-08-02       Impact factor: 12.300
  1 in total
  1 in total

Review 1.  Temozolomide Efficacy and Metabolism: The Implicit Relevance of Nanoscale Delivery Systems.

Authors:  Daria Petrenko; Vladimir Chubarev; Nikita Syzrantsev; Nafeeza Ismail; Vadim Merkulov; Susanna Sologova; Ekaterina Grigorevskikh; Elena Smolyarchuk; Renad Alyautdin
Journal:  Molecules       Date:  2022-05-30       Impact factor: 4.927
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.